Flurpiridaz F-18: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Flurpiridaz F-18. Educational only — not medical advice.

Labeled uses

FLYRCADO is indicated for positron emission tomography (PET) myocardial perfusion imaging (MPI) under rest or stress (pharmacologic or exercise) in adult patients with known or suspected coronary artery disease (CAD) to evaluate for myocardial ischemia and infarction.

Source: FDA labeling via NIH DailyMed (set 3bb6caf8…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.